Oncolytics Biotech (ONCY) Depreciation and Depletion (2019 - 2025)

Oncolytics Biotech (ONCY) has 7 years of Depreciation and Depletion data on file, last reported at $50.14 in Q3 2025.

• On a quarterly basis, Depreciation and Depletion fell 0.88% year-over-year to $50.14 in Q3 2025; TTM through Sep 2025 was $316780.0, a 69.97% increase from a year earlier, with the FY2025 full-year figure at $70000.0, down 19.54% from the prior year.
• Depreciation and Depletion for Q3 2025 stood at $50.14, down from $49798.2 in the prior quarter.
• Over the last five years, Depreciation and Depletion for ONCY reached as high as $217450.6 in Q4 2024 and fell as low as $50.14 in Q3 2025.
• Historically, Depreciation and Depletion has averaged $61265.8 across 5 years, with a median of $58009.8 in 2022.
• On a YoY basis, Depreciation and Depletion climbed as much as 236.41% in 2024 and fell as far as 99.92% in 2024.
• Year by year, Depreciation and Depletion stood at $58618.8 in 2021, then declined by 3.23% to $56726.1 in 2022, then climbed by 13.95% to $64639.1 in 2023, then jumped by 236.41% to $217450.6 in 2024, then sank by 99.98% to $50.14 in 2025.
• Per Business Quant data, the three most recent Depreciation and Depletion figures were $50.14 in Q3 2025, $49798.2 in Q2 2025, and $49481.1 in Q1 2025.